A Review on Various Uses of N-Acetyl Cysteine

Overview

Journal Cell J

Specialty Cell Biology

Date 2017 Apr 4

PMID 28367412

Citations 127

Authors

Vida Mokhtari

Parvaneh Afsharian

Maryam Shahhoseini

Seyed Mehdi Kalantar

Ashraf Moini

Affiliations

Soon will be listed here.

Abstract

N-acetyl cysteine (NAC), as a nutritional supplement, is a greatly applied antioxidant and . NAC is a precursor of L-cysteine that results in glutathione elevation biosynthesis. It acts directly as a scavenger of free radicals, especially oxygen radicals. NAC is a powerful antioxidant. It is also recommended as a potential treatment option for different disorders resulted from generation of free oxygen radicals. Additionally, it is a protected and endured mucolytic drug that mellows tenacious mucous discharges. It has been used for treatment of various diseases in a direct action or in a combination with some other medications. This paper presents a review on various applications of NAC in treatment of several diseases.

Citing Articles

Effects of vitamin D and L-cysteine cosupplementation on circulating bioavailable and total 25-hydroxy-vitamin D, the free/total testosterone ratio and inflammatory biomarkers in healthy vitamin D-deficient African Americans: a placebo-controlled....

Jain S, Margret J, Zachary Jr A, Lally M, Vanchiere J, Mhanna M BMJ Nutr Prev Health. 2025; 7(2):e000856.

PMID: 39882299 PMC: 11773665. DOI: 10.1136/bmjnph-2023-000856.

Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health.

Pekdemir B, Raposo A, Saraiva A, Lima M, Alsharari Z, BinMowyna M Nutrients. 2025; 16(24.

PMID: 39770989 PMC: 11677798. DOI: 10.3390/nu16244368.

Behavioral Test Scores Could Be Linked to the Protein Expression Values of p62 and GLAST in the Brains of Mice with Neuropsychiatric Disorder-Related Behaviors.

Ikeda Y, Nakashima M, Yoshikawa S, Taniguchi K, Suga N, Matsuda S Biology (Basel). 2025; 13(12.

PMID: 39765706 PMC: 11672909. DOI: 10.3390/biology13121039.

The microbiome diversifies -acyl lipid pools - including short-chain fatty acid-derived compounds.

Mannochio-Russo H, Charron-Lamoureux V, van Faassen M, Lamichhane S, Nunes W, Deleray V bioRxiv. 2024; .

PMID: 39554097 PMC: 11565975. DOI: 10.1101/2024.10.31.621412.

Dietary supplementation with N-acetyl-L-cysteine ameliorates hyperactivated ERK signaling in the endometrium that is linked to poor pregnancy outcomes following ovarian stimulation in pigs.

Cheng L, Shi Z, Yue Y, Wang Y, Qin Y, Zhao W J Anim Sci Biotechnol. 2024; 15(1):148.

PMID: 39501409 PMC: 11539329. DOI: 10.1186/s40104-024-01109-1.

References

Martinez-Banaclocha M . N-acetyl-cysteine in the treatment of Parkinson's disease. What are we waiting for?. Med Hypotheses. 2012; 79(1):8-12. DOI: 10.1016/j.mehy.2012.03.021. View

Harada M, Kishimoto K, Furuhashi T, Naito K, Nakashima Y, Kawaguchi Y . Infertility observed in reproductive toxicity study of N-acetyl-L-cysteine in rats. Biol Reprod. 2003; 69(1):242-7. DOI: 10.1095/biolreprod.102.013862. View

Poston L, Raijmakers M . Trophoblast oxidative stress, antioxidants and pregnancy outcome--a review. Placenta. 2004; 25 Suppl A:S72-8. DOI: 10.1016/j.placenta.2004.01.003. View

Eftekhari P, Hajizadeh S, Raoufy M, Masjedi M, Yang M, Hansbro N . Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma. EXCLI J. 2015; 12:184-92. PMC: 4531779. View

Wierzbicki A . Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res. 2007; 4(2):143-50. DOI: 10.3132/dvdr.2007.033. View

Veldman B, Wijn A, Knoers N, Praamstra P, Horstink M . Genetic and environmental risk factors in Parkinson's disease. Clin Neurol Neurosurg. 1998; 100(1):15-26. DOI: 10.1016/s0303-8467(98)00009-2. View

Cai T, Fassina G, Morini M, Aluigi M, Masiello L, Fontanini G . N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest. 1999; 79(9):1151-9. View

Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S . Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations. Lancet Neurol. 2015; 14(8):855-866. PMC: 5217462. DOI: 10.1016/S1474-4422(15)00006-X. View

Beloosesky R, Gayle D, Amidi F, Nunez S, Babu J, Desai M . N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol. 2006; 194(1):268-73. DOI: 10.1016/j.ajog.2005.06.082. View

10.

Agid Y, Ruberg M, Hirsch E, Raisman-Vozari R, Vyas S, Faucheux B . Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Adv Neurol. 1993; 60:148-64. View

11.

Millea P . N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009; 80(3):265-9. View

12.

Li J, Wang W, Baines K, Bowden N, Hansbro P, Gibson P . IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J Immunol. 2010; 185(7):4401-9. DOI: 10.4049/jimmunol.1001039. View

13.

Crowell C, Lyew R, Givens M, Deering S . Caring for the mother, concentrating on the fetus: intravenous N-acetylcysteine in pregnancy. Am J Emerg Med. 2008; 26(6):735.e1-2. DOI: 10.1016/j.ajem.2007.11.017. View

14.

Moreno-Otero R, Trapero-Marugan M . Hepatoprotective effects of antioxidants in chronic hepatitis C. World J Gastroenterol. 2010; 16(15):1937-8. PMC: 2856839. DOI: 10.3748/wjg.v16.i15.1937. View

15.

Moreira P, Harris P, Zhu X, Santos M, Oliveira C, Smith M . Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis. 2007; 12(2):195-206. DOI: 10.3233/jad-2007-12210. View

16.

Moini A, Tadayon S, Tehranian A, Mohammadi Yeganeh L, Akhoond M, Yazdi R . Association of thrombophilia and polycystic ovarian syndrome in women with history of recurrent pregnancy loss. Gynecol Endocrinol. 2012; 28(8):590-3. DOI: 10.3109/09513590.2011.650754. View

17.

Blesa S, Cortijo J, Martinez-Losa M, Mata M, Seda E, Santangelo F . Effectiveness of oral N -acetylcysteine in a rat experimental model of asthma. Pharmacol Res. 2002; 45(2):135-40. DOI: 10.1006/phrs.2001.0917. View

18.

Cheraghi E, Mehranjani M, Shariatzadeh M, Nasr Esfahani M, Ebrahimi Z . Co-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI. Int J Fertil Steril. 2014; 8(2):119-28. PMC: 4107684. View

19.

Amin A, Shaaban O, Bediawy M . N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss. Reprod Biomed Online. 2008; 17(5):722-6. DOI: 10.1016/s1472-6483(10)60322-7. View

20.

Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Ciccolo A, Centorrino T . Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J. 2001; 15(7):1187-200. DOI: 10.1096/fj.00-0526hyp. View